ImmunologybioRxivPreprint
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
A. L. Cathcart, C. Havenar-Daughton, F. A. Lempp…·C. M. Hebner
This paper evaluates the in vitro and in vivo efficacy of dual-action monoclonal antibodies VIR-7831 and VIR-7832 against SARS-CoV-2, showing potent neutralization and reduced viral load in a hamster model.
DOI 10.1101/2021.03.09.434607